NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)
NIH plans to invite eligible US small businesses to apply for STTR grants (R41/R42) supporting collaborative research and technology development, with clinical trials not allowed.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (projected)
Funding Amounts: Award amounts and ceilings not yet announced; typical STTR awards support Phase I and II projects, multi-year funding possible.
Summary: Supports U.S. small businesses in collaborative R&D with research institutions to develop and commercialize innovative health-related technologies aligned with NIH priorities.
Key Information: Forecasted opportunity; details and deadlines are subject to change.
Description
This forecasted funding opportunity from the National Institutes of Health (NIH) invites eligible U.S. small businesses to apply for Small Business Technology Transfer (STTR) grants (R41/R42 activity codes), including Phase I, Phase II, Direct to Phase II (NIH only), and Fast-Track (NIH only) applications. The program aims to foster partnerships between small businesses and research institutions to advance the development and commercialization of innovative health-related technologies that address NIH mission areas. A broad range of NIH Institutes and Centers participate, supporting projects in diverse biomedical and behavioral research fields.
